Respiratory Infections

The FDA has added a ventilator developed by NASA to the list of authorized ventilators.

A round up of the top infectious disease news from April.

How closely related were the RSV strains in a Louisiana NICU outbreak?

A review of our latest COVID-19 coverage.

Treatment with remdesivir was not associated with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.

A New York City nurse reflects on "peak-week" in a COVID unit.

The SIMPLE trial appears to have demonstrated that patients receiving the 5-day dose duration achieved similar improvement in clinical status compared to patients who received the 10-day dosing duration.

A daily round up of our COVID-19 coverage.

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

Over half of residents with positive test results were asymptomatic at the time of testing, during a recent survey.

A trio of clinicians pen perspective on the federal and state efforts being made to reduce rapid and severe virus spread in at-risk facilities.

A pair of experts cite fair innings in their debate, wondering if age should play a role in deciding who qualifies for life-saving coronavirus treatments.

Tune in for a daily COVID-19 update.

Hypertension, obesity, and diabetes are the most observed comorbidities among infected patients in the New York City area.

New expert recommendations follow from evidence showing the virus is a thrombo-inflammatory process that can affect multiple organs in addition to the lungs.

Older patients who live alone are at a higher risk of being hospitalized for respiratory disease, according to a new study.

In part 2 of the interview, Ryan W. Stevens, PharmD, BCIDP, discusses the risks associated with convalescent plasma and highlights what clinicians should know.

In part 1 of our interview, Ryan W. Stevens, PharmD, BCIDP, provides an overview of how convalescent plasma has been used to treat infectious diseases including coronaviruses.

Two infants who presented to New York hospitals with fevers ended up testing positive for COVID-19 and serve as a reminder of the importance of infection-prevention protocols, according to a new paper.

Stay up to date on the latest coronavirus news from Friday, April 24th.

As much of the American economy has been restricted, economic impacts are beginning to translate into food insecurity.

The FDA released a drug safety communication cautioning against the use of hydroxychloroquine or chloroquine for COVID-19 outside of hospital and clinical trial settings.

Hong Kong applied preventative measures learned during the SARS epidemic when trying to control the novel coronavirus outbreak.

Stephen Klasko, MD, MBA, CEO of Thomas Jefferson University Hospitals, discusses what COVID-19 has taught hospitals about preparing for pandemics.

This test, which will be marketed throughout the United States, can instantly detect antibodies in whole blood, serum, and plasma for SARS-CoV-2.

A new report from the CDC shows the story of COVID-19 is very different from one state to the next.

Listen in for a daily COVID-19 news roundup.

Younger patients hospitalized with COVID-19 frequently feature obesity as an underlying condition.

Mixed results have led the authors of a retrospective analysis to caution use of hydroxychloroquine outside of clinical trials.